Skip to main content
. 2022 Dec 2;4(48):1088–1091. doi: 10.46234/ccdcw2022.219

Table 2. The prevalence of HPV-16, HPV-18, and the other 12 hrHPV subtypes by age group during 2019–2021 in rural Guangzhou, China (N=159,251).

Age group Total participants
(%)
HPV-16 HPV-18 Pooled 12 hrHPV
No. of positive Positive rate (%)
(95% CI)
Prevalence ratio (95% CI) No. of positive Positive rate (%)
(95% CI)
Prevalence ratio (95% CI) No. of positive Positive rate (%)
(95% CI)
Prevalence ratio (95% CI)
Abbreviation: hrHPV=high-risk human papillomavirus; CI=confidence interval.
“–” means not applicable.
35–39 36,914 (23.18) 262 0.71 (0.63–0.80) 1.00 136 0.37 (0.31–0.44) 1.00 1,623 4.40 (4.19–4.61) 1.00
40–44 29,917 (18.78) 190 0.64 (0.55–0.73) 0.89 (0.74–1.08) 93 0.31 (0.25–0.38) 0.84 (0.64–1.11) 1,243 4.15 (3.93–4.39) 0.94 (0.88–1.02)
45–49 34,974 (21.96) 206 0.59 (0.51–0.68) 0.83 (0.69–1.00) 104 0.30 (0.24–0.36) 0.81 (0.62–1.05) 1,511 4.32 (4.11–4.54) 0.98 (0.92–1.05)
50–54 31,151 (19.56) 232 0.75 (0.65–0.85) 1.05 (0.88–1.26) 112 0.36 (0.30–0.43) 0.98 (0.75–1.26) 1,364 4.38 (4.16–4.61) 1.00 (0.93–1.07)
55–59 18,275 (11.48) 164 0.90 (0.77–1.05) 1.26 (1.03–1.54) 53 0.29 (0.22–0.38) 0.79 (0.56–1.09) 936 5.12 (4.81–5.45) 1.16 (1.07–1.26)
60–64 8,020 (5.04) 76 0.95 (0.75–1.19) 1.34 (1.02–1.73) 40 0.50 (0.36–0.69) 1.35 (0.93–1.94) 491 6.12 (5.61–6.67) 1.39 (1.26–1.54)
Total 159,251 1,130 0.71 (0.67–0.75) 538 0.34 (0.31–0.37) 7,168 4.50 (4.40–4.60)